Search research articles
Contact Us
Filters
Showing results (91-100 of 114) with videos related to
Page
of 12
Sort By:
Emerging Infectious Diseases
|
July 21, 2020
Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France
Marie Jaspard, Nathalie Butel, Najoua El Helali, et al.
Microbiology Spectrum
|
May 22, 2025
Evaluation of the role of <i>whiB6</i> and <i>kdpDE</i> in the dominant multidrug-resistant clone <i>Mycobacterium tuberculosis</i> B0/W148
Isabelle Bonnet, Mickael Orgeur, Florence Brossier, et al.
ERJ Open Research
|
September 25, 2024
Patients at risk of nontuberculous mycobacterial pulmonary disease who need testing evaluated using a modified Delphi process by European experts
Michael R Loebinger, Stefano Aliberti, Charles Haworth, et al.
Plos Neglected Tropical Diseases
|
September 9, 2022
Epidemiology of infection by pulmonary non-tuberculous mycobacteria in French Guiana 2008-2018
Milène Chaptal, Claire Andrejak, Timothée Bonifay, et al.
Journal of Medical Microbiology
|
August 4, 2012
Temporal interferon-gamma release response to Mycobacterium kansasii infection in an anorexia nervosa patient
Marie-Anne Cosson, Jean-Baptiste Bertrand, Clémence Martin, et al.
NPJ Drug Discovery
|
April 7, 2025
Structural and mechanistic study of a novel inhibitor analogue of <i>M. tuberculosis</i> cytochrome bc<sub>1</sub>:aa<sub>3</sub>
Amit K Verma, Robbert Q Kim, Dirk A Lamprecht, et al.
Emerging Infectious Diseases
|
March 2, 2025
Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment
Valentina Gerussi, Tania Petersen, Isabelle Bonnet, et al.
Emerging Infectious Diseases
|
April 20, 2019
Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis
Lawrence Mbuagbaw, Lorenzo Guglielmetti, Catherine Hewison, et al.
The Journal of Antimicrobial Chemotherapy
|
December 19, 2015
Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial
Olivier Lortholary, Caroline Roussillon, Céline Boucherie, et al.
The European Respiratory Journal
|
May 19, 2022
Rifapentine access in Europe: growing concerns over key tuberculosis treatment component
Lorenzo Guglielmetti, Gunar Günther, Claude Leu, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 114) with videos related to
Sort By:
Page
of 12
Emerging Infectious Diseases
|
July 21, 2020
Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France
Marie Jaspard, Nathalie Butel, Najoua El Helali, et al.
Microbiology Spectrum
|
May 22, 2025
Evaluation of the role of <i>whiB6</i> and <i>kdpDE</i> in the dominant multidrug-resistant clone <i>Mycobacterium tuberculosis</i> B0/W148
Isabelle Bonnet, Mickael Orgeur, Florence Brossier, et al.
ERJ Open Research
|
September 25, 2024
Patients at risk of nontuberculous mycobacterial pulmonary disease who need testing evaluated using a modified Delphi process by European experts
Michael R Loebinger, Stefano Aliberti, Charles Haworth, et al.
Plos Neglected Tropical Diseases
|
September 9, 2022
Epidemiology of infection by pulmonary non-tuberculous mycobacteria in French Guiana 2008-2018
Milène Chaptal, Claire Andrejak, Timothée Bonifay, et al.
Journal of Medical Microbiology
|
August 4, 2012
Temporal interferon-gamma release response to Mycobacterium kansasii infection in an anorexia nervosa patient
Marie-Anne Cosson, Jean-Baptiste Bertrand, Clémence Martin, et al.
NPJ Drug Discovery
|
April 7, 2025
Structural and mechanistic study of a novel inhibitor analogue of <i>M. tuberculosis</i> cytochrome bc<sub>1</sub>:aa<sub>3</sub>
Amit K Verma, Robbert Q Kim, Dirk A Lamprecht, et al.
Emerging Infectious Diseases
|
March 2, 2025
Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment
Valentina Gerussi, Tania Petersen, Isabelle Bonnet, et al.
Emerging Infectious Diseases
|
April 20, 2019
Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis
Lawrence Mbuagbaw, Lorenzo Guglielmetti, Catherine Hewison, et al.
The Journal of Antimicrobial Chemotherapy
|
December 19, 2015
Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial
Olivier Lortholary, Caroline Roussillon, Céline Boucherie, et al.
The European Respiratory Journal
|
May 19, 2022
Rifapentine access in Europe: growing concerns over key tuberculosis treatment component
Lorenzo Guglielmetti, Gunar Günther, Claude Leu, et al.
Page
of 12